Lv1
90 积分 2024-11-12 加入
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2个月前
已完结
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
5个月前
已关闭
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
5个月前
已完结
Perforin and granzymes: function, dysfunction and human pathology
5个月前
已完结
Reduced CAR T expansion post infusion is associated with poor survival in patients with large B cell lymphoma after two or more therapies
6个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
6个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
6个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
7个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
8个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
9个月前
已关闭
皖公网安备34019202002308
